Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRKACB Antikörper (pThr198) (AbBy Fluor® 350)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch PRKACB in IF (cc) und IF (p). Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN877663
426,37 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 20 bis 25 Werktagen

Kurzübersicht für PRKACB Antikörper (pThr198) (AbBy Fluor® 350) (ABIN877663)

Target

Alle PRKACB Antikörper anzeigen
PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

Reaktivität

  • 57
  • 19
  • 12
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 55
  • 2
Kaninchen

Klonalität

  • 55
  • 2
Polyklonal

Konjugat

  • 24
  • 5
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PRKACB Antikörper ist konjugiert mit AbBy Fluor® 350

Applikation

  • 30
  • 25
  • 17
  • 12
  • 12
  • 6
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Bindungsspezifität

    • 14
    • 7
    • 6
    • 6
    • 4
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr198

    Verwendungszweck

    Phospho-PKA alpha + beta (Thr198) Polyclonal Antibody, AbBy Fluor-350 Conjugated

    Kreuzreaktivität

    Human, Ratte

    Homologie

    Mouse,Dog,Cow,Pig,Chicken

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic phosphopeptide derived from human PRKACB around the phosphorylation site of Thr198

    Isotyp

    IgG
  • Applikationshinweise

    IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

    Andere Bezeichnung

    PRKACB

    Hintergrund

    Synonyms: PKA alpha + betaThr198, C alpha, cAMP dependent protein kinase beta catalytic subunit, cAMP dependent protein kinase alpha catalytic subunit, cAMP dependent protein kinase catalytic subunit alpha, cAMP dependent protein kinase catalytic subunit beta, Cs, PKA, PKA C, PKA C alpha, PKA C beta, PKACA, PKACB, PRKACA, PRKACB, Protein kinase cAMP dependent catalytic alpha, Protein kinase cAMP dependent catalytic beta, Protein kinase cAMP dependent catalytic beta isoform a, Protein kinase cAMP dependent catalytic beta isoform b.

    Background: PRKACA and PRKACB are members of the Ser/Thr protein kinase family and are a catalytic subunit of cAMP-dependent protein kinase. cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits.PKA alpha + beta (catalytic subunits) (phospho Thr198)

    Gen-ID

    5567

    Pathways

    AMPK Signaling, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Sie sind hier:
Chat with us!